Variant report
Variant | esv3419804 |
---|---|
Chromosome Location | chr1:220133229-220135027 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:25)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:25 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr1:220133296-220133448 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr1:220133179-220133482 | K562 | blood: | n/a | n/a |
3 | BACH1 | chr1:220133249-220133472 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CBX3 | chr1:220133132-220133547 | K562 | blood: | n/a | n/a |
5 | ELF1 | chr1:220133186-220133548 | K562 | blood: | n/a | n/a |
6 | EP300 | chr1:220133208-220133425 | K562 | blood: | n/a | n/a |
7 | HCFC1 | chr1:220133207-220133341 | K562 | blood: | n/a | n/a |
8 | KAP1 | chr1:220131954-220133477 | U2OS | brain: | n/a | n/a |
9 | KAP1 | chr1:220131650-220133464 | HEK293 | kidney: | n/a | n/a |
10 | MAFF | chr1:220133181-220133457 | K562 | blood: | n/a | chr1:220133344-220133362 |
11 | MAFF | chr1:220133215-220133484 | HepG2 | liver: | n/a | chr1:220133344-220133362 |
12 | MAFK | chr1:220133212-220133494 | H1-hESC | embryonic stem cell: | n/a | n/a |
13 | MAFK | chr1:220133210-220133479 | K562 | blood: | n/a | n/a |
14 | MAFK | chr1:220133224-220133511 | HepG2 | liver: | n/a | n/a |
15 | MYC | chr1:220133482-220133540 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | RAD21 | chr1:220133272-220133381 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | RCOR1 | chr1:220133192-220133440 | K562 | blood: | n/a | n/a |
18 | RCOR1 | chr1:220133186-220133449 | K562 | blood: | n/a | n/a |
19 | REST | chr1:220134541-220134744 | K562 | blood: | n/a | n/a |
20 | TBL1XR1 | chr1:220133242-220133513 | K562 | blood: | n/a | n/a |
21 | USF2 | chr1:220133281-220133472 | K562 | blood: | n/a | n/a |
22 | ZC3H11A | chr1:220133206-220133492 | K562 | blood: | n/a | n/a |
23 | ZNF143 | chr1:220133234-220133420 | K562 | blood: | n/a | n/a |
24 | ZNF143 | chr1:220133230-220133456 | H1-hESC | embryonic stem cell: | n/a | n/a |
25 | ZNF274 | chr1:220132928-220133511 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SLC30A10 | TF binding region |
ENSG00000221673 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs141145921 | chr1:220133230-220133231 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs367940539 | chr1:220133279-220133280 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs542412221 | chr1:220133281-220133282 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs77685442 | chr1:220133306-220133307 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs572761000 | chr1:220133324-220133325 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs11118472 | chr1:220133340-220133341 | Weak transcription Enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs564699786 | chr1:220133345-220133346 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs181265624 | chr1:220133357-220133358 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs13375889 | chr1:220133364-220133365 | Weak transcription Enhancers | TF binding region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs550614500 | chr1:220133368-220133369 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs560960993 | chr1:220133370-220133371 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs570597689 | chr1:220133391-220133392 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs186374282 | chr1:220133400-220133401 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs529551811 | chr1:220133418-220133419 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs549558056 | chr1:220133446-220133447 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs566376962 | chr1:220133456-220133457 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs535305231 | chr1:220133462-220133463 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs551766382 | chr1:220133487-220133488 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs190448581 | chr1:220133508-220133509 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs571585417 | chr1:220133516-220133517 | Weak transcription Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs375430929 | chr1:220133602-220133603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200208175 | chr1:220133609-220133610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183097972 | chr1:220133611-220133612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs71169418 | chr1:220133637-220133638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12145500 | chr1:220133643-220133644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs12142050 | chr1:220133645-220133646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs12142052 | chr1:220133653-220133654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12145502 | chr1:220133655-220133656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376123846 | chr1:220133660-220133661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs12409859 | chr1:220133663-220133664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184015888 | chr1:220133664-220133665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544167774 | chr1:220133665-220133666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12142054 | chr1:220133671-220133672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs12411083 | chr1:220133672-220133673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12145505 | chr1:220133673-220133674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs12408531 | chr1:220133690-220133691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187028712 | chr1:220133699-220133700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71169419 | chr1:220133708-220133709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191974649 | chr1:220133709-220133710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557222982 | chr1:220133717-220133718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs34349048 | chr1:220133718-220133719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12411092 | chr1:220133727-220133728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs67229006 | chr1:220133729-220133730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12409864 | chr1:220133731-220133732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374177792 | chr1:220133737-220133738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs184279479 | chr1:220133738-220133739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189046284 | chr1:220133741-220133742 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12409865 | chr1:220133743-220133744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs12145529 | chr1:220133749-220133750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370749719 | chr1:220133750-220133751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Autism | 14699429 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:220129200-220145800 | Weak transcription | HepG2 | liver |
2 | chr1:220132000-220133400 | Enhancers | Rectal Mucosa Donor 29 | rectum |
3 | chr1:220132000-220138800 | Weak transcription | Aorta | Aorta |
4 | chr1:220132200-220144200 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
5 | chr1:220132400-220133400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
6 | chr1:220132400-220133600 | Enhancers | Fetal Intestine Large | intestine |
7 | chr1:220132400-220143200 | Weak transcription | Colonic Mucosa | Colon |
8 | chr1:220132600-220133600 | Enhancers | Fetal Intestine Small | intestine |
9 | chr1:220132800-220141000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr1:220132800-220177000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
11 | chr1:220133000-220133400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
12 | chr1:220133000-220133600 | Enhancers | Small Intestine | intestine |
13 | chr1:220133000-220133600 | Enhancers | K562 | blood |
14 | chr1:220133000-220141200 | Weak transcription | Duodenum Mucosa | Duodenum |
15 | chr1:220133400-220133600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr1:220133400-220138600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
17 | chr1:220133600-220134600 | Weak transcription | K562 | blood |
18 | chr1:220133600-220140800 | Weak transcription | Fetal Intestine Large | intestine |
19 | chr1:220133600-220141000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr1:220133600-220142200 | Weak transcription | Small Intestine | intestine |
21 | chr1:220134600-220135000 | Enhancers | K562 | blood |
22 | chr1:220135000-220135200 | Flanking Active TSS | K562 | blood |